Showing 21 - 40 results of 319 for search '"Organ transplant"', query time: 0.08s Refine Results
  1. 21

    Dendritic Cell-Based Approaches for Therapeutic Immune Regulation in Solid-Organ Transplantation by Giuseppe Vassalli

    Published 2013-01-01
    “…Intravenous injection of immature DCs of either donor or host origin at the time of transplantation have prolonged allograft survival in solid-organ transplant models. DCs can be treated with pharmacological agents before injection, which may attenuate their maturation in vivo. …”
    Get full text
    Article
  2. 22

    SARS-CoV-2 vaccine-elicited immune responses in solid organ transplant recipients by Euri Seo, Eui-Cheol Shin, Min Kyung Jung

    Published 2024-12-01
    Subjects: “…solid organ transplant recipients; sars-cov-2 vaccine; humoral immune responses; cellular immune responses…”
    Get full text
    Article
  3. 23
  4. 24
  5. 25

    Concomitant abdominal organ transplantation alongside lung transplantation: An ISHLT transplant database analysis by Renita Wilson, BS, J. Asher Jenkins, MD, Juan Maria Farina, MD, Blake Langlais, MS, Bashar Aqel, MD, Ashraf Omar, MD, Jonathan D’Cunha, MD, PhD, Pedro Reck dos Santos, MD, PhD

    Published 2025-02-01
    “…Background: Concomitant abdominal organ transplant of the liver, kidney, and/or pancreas with lung transplant (Con-AbLTx) may be considered for appropriate patients who present with end-stage disease of multiple organ systems. …”
    Get full text
    Article
  6. 26

    Medical Gases: A Novel Strategy for Attenuating Ischemia—Reperfusion Injury in Organ Transplantation? by Arunotai Siriussawakul, Lucinda I. Chen, John D. Lang

    Published 2012-01-01
    “…Ischemia reperfusion injury (IRI) is an inevitable clinical consequence in organ transplantation. It can lead to early graft nonfunction and contribute to acute and chronic graft rejection. …”
    Get full text
    Article
  7. 27
  8. 28
  9. 29
  10. 30
  11. 31
  12. 32
  13. 33
  14. 34

    Immunotherapy and Antivascular Targeted Therapy in Patients’ Treatment with Concurrent Malignant Tumors after Organ Transplantation: Opportunity or Challenge by Bairu Shen, Zi Guo, Peng Huang, Minghua Tan, Xiaoshen Zhang, Siyao Lin, Changshan Song, Jiaqing Wang, Minqian Huang

    Published 2022-01-01
    “…To analyze the therapeutic effects and organ rejection of anti-PD-1 immunotherapy or antivascular targeting therapy on patients with combined malignancies after organ transplantation. Methods. We collected retrospective studies on “post-transplantation, cancer, immunotherapy, and vascular targeting therapy” in Embase, Wanfang database, Cochrane Library, VIP databases, CNKI, and PubMed, and the case data were organized and analyzed. …”
    Get full text
    Article
  15. 35
  16. 36
  17. 37
  18. 38
  19. 39

    The Role of The Cytomegalovirus Antigenemia Assay in the Detection and Prevention of Cytomegalovirus Syndrome and Disease in Solid Organ Transplant Recipients: A Review of the British Columbia Experience by Erica D Greanya, Nilufar Partovi, Eric M Yoshida, R Jean Shapiro, Robert D Levy, Chris H Sherlock, Gwen M Stephens

    Published 2005-01-01
    “…BACKGROUND: The pp65 cytomegalovirus (CMV) antigenemia assay has been used as a means of guiding the pre-emptive therapy of CMV disease in solid organ transplant (SOT) recipients. Recently, concerns have been raised regarding the utility of the test to accurately and precisely detect viral activity early enough to reduce the morbidity and mortality associated with CMV.…”
    Get full text
    Article
  20. 40

    Low Seroconversion after One Dose of AS03-Adjuvanted H1N1 Pandemic Influenza Vaccine in Solid-Organ Transplant Recipients by Mariangela R Resende, Shahid Husain, Jonathan Gubbay, Lianne Singer, Edward Cole, Eberhard L Renner, Coleman Rotstein

    Published 2013-01-01
    “…As a result, solid-organ transplant (SOT) recipients were targeted as a priority group to receive AS03-adjuvanted H1N1 influenza vaccine during 2009.…”
    Get full text
    Article